| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.71▼ | 1.71▼ | 1.71▼ | 1.66▲ | 1.74▼ |
| MA10 | 1.72▼ | 1.70▼ | 1.72▼ | 1.64▲ | 2.05▼ |
| MA20 | 1.71▼ | 1.67▲ | 1.66▲ | 1.79▼ | 1.91▼ |
| MA50 | 1.68▲ | 1.72▼ | 1.74▼ | 2.00▼ | 1.72▼ |
| MA100 | 1.82▼ | 1.84▼ | 1.86▼ | 1.94▼ | 1.13▲ |
| MA200 | 1.91▼ | 2.07▼ | 2.11▼ | 1.93▼ | 1.42▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.007▲ | 0.009▲ | 0.002▲ | -0.072▼ |
| RSI | 50.696▲ | 50.338▲ | 50.007▲ | 42.415▼ | 46.731▼ |
| STOCH | 58.148 | 36.785 | 32.407 | 39.536 | 33.504 |
| WILL %R | -55.556 | -81.818▼ | -81.818▼ | -61.404 | -66.026 |
| CCI | -50.045 | -36.230 | -36.230 | -25.145 | -64.584 |
|
Friday, February 27, 2026 04:46 AM
About IN8bio Inc. IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tu ...
|
|
Tuesday, February 24, 2026 05:58 AM
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune diseases, today announced that William Ho, CEO ...
|
|
Monday, February 09, 2026 11:37 AM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be IN8bio (INAB). The reason why I want to go over this biotech next is because it reported ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/03/26 | 1.67 | 1.73 | 1.6201 | 1.70 | 37,590 |
| 27/02/26 | 1.69 | 1.7999 | 1.66 | 1.70 | 43,016 |
| 26/02/26 | 1.68 | 1.81 | 1.68 | 1.71 | 23,383 |
| 25/02/26 | 1.60 | 1.7199 | 1.5901 | 1.66 | 16,618 |
| 24/02/26 | 1.53 | 1.59 | 1.51 | 1.55 | 20,292 |
| 23/02/26 | 1.54 | 1.60 | 1.50 | 1.51 | 0 |
| 20/02/26 | 1.63 | 1.69 | 1.48 | 1.55 | 59,157 |
| 19/02/26 | 1.67 | 1.68 | 1.58 | 1.60 | 51,587 |
| 18/02/26 | 1.73 | 1.7899 | 1.66 | 1.68 | 34,102 |
| 17/02/26 | 1.75 | 1.79 | 1.72 | 1.72 | 42,003 |
|
|
||||
|
|
||||
|
|